top of page

Free Biopharma Daily Stock Updates - 07/09/21

  • Writer: BPIQ
    BPIQ
  • Jul 9, 2021
  • 2 min read

$XBI $133.8 +1.4%

Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!

COVID Updates

$HGEN +2.2% UK’s MHRA accepts Humanigen’s submission of Lenzilumab for Marketing Authorization in COVID-19 for expedited rolling review. source



Pipeline Updates

$IMAB +7.7% I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and AI Technology Platforms. source


$MDWD +5.8% MediWound Announces Peer-Reviewed Paper Detailing EscharEx Phase 2 Randomized Control Trial Results Published in the Online Wound Repair and Regeneration Journal. source


$GALT +25.0% Galectin Therapeutics Announces Positive Top-Line Results from a Phase 1b Clinical Trial Extension of Belapectin in Combination with KEYTRUDA® in Advanced Metastatic Melanoma and Head and Neck Cancer. source


$AMTI +2.3% Applied Molecular Transport Presents Additional Positive Data from Oral AMT-101 Phase 1b in Ulcerative Colitis at ECCO ‘21 Virtual Congress. source


$MTEM +1.2% Molecular Templates, Inc. Announces Dosing of First Subject in Phase 1 Study of MT-6402 in PD-L1-Positive Solid Tumors. source


$SGTX -25.3% Sigilon Therapeutics Announces Clinical Hold on SIG-001 Phase 1/2 Study in Hemophilia A. source


$BLUE +0.5% bluebird bio Announces Positive Recommendation by PRAC Regarding Article 20 Safety Referral Review of ZYNTEGLO™ Gene Therapy for Transfusion-Dependent β-thalassemia and Marketing to Resume in EU. source


$MORF +6.4% Morphic Reports New Data from Positive Phase 1 Study of MORF-057, Oral Integrin Inhibitor Candidate for IBD. source



Financial Updates

$RPHM -2.5% Reneo Pharmaceuticals Announces Partial Waiver of Lock-Up Restriction. source


$IMPL +13.5% On 7/7 Impel NeuroPharma Enters Into a $50 Million Debt Financing Agreement With Oxford Finance LLC and Silicon Valley Bank. source


$LMNL +4.9% Liminal BioSciences Announces Closing of Sale of Plasma-Derived Therapeutics Manufacturing Facility source

Posted by FS

 
 
 

Comments

bottom of page